Lymphangiosarcoma in a Chronic Lymphedematous Limb: A Case Report

1995 ◽  
Vol 81 (5) ◽  
pp. 381-382 ◽  
Author(s):  
Maria Victoria Lasa ◽  
Pedro Mateo ◽  
Natividad Bascón ◽  
José Baquedano ◽  
Fernando Fuertes ◽  
...  

A 69-year-old-woman developed a lymphangiosarcoma of the limb on chronic lymphedema after radical mastectomy and radiotherapy for primary breast cancer 12 years before. Since 1948, when Stewart and Treves described this entity, 200 cases have been described. We report this case because of its extremely rare frequency. Concepts of etiology, treatment and prognosis are reviewed.

2017 ◽  
Author(s):  
Anne Kuritzky ◽  
Laila Khazai ◽  
Roberto Diaz ◽  
Christine Laronga

The identification of an axillary metastasis in the absence of a primary breast cancer can pose a diagnostic and therapeutic dilemma. The clinician should first use more sensitive imaging modalities, such as breast magnetic resonance imaging, to attempt to find the primary index lesion. If the primary cancer remains occult and the molecular markers are consistent with a breast origin, then the recommended treatment includes multimodality therapy including surgery, chemotherapy/endocrine treatment, and radiation. Historically, the modified radical mastectomy was the standard of practice. Recently, in the era of improved adjuvant therapies, breast-conserving surgery with irradiation is also being considered. Multiple retrospective reviews have shown no difference in survival or recurrence with these two surgical pathways. However, due to the rare nature of this clinical presentation, no multiinstitutional or prospective clinical trial data are available.  Key words: axillary lymph node dissection, axillary metastasis, breast cancer, breast conservation, local recurrence, occult primary tumor, radiotherapy 


Medicine ◽  
2019 ◽  
Vol 98 (16) ◽  
pp. e14989 ◽  
Author(s):  
Alexandros Papalampros ◽  
Eustratia Mpaili ◽  
Demetrios Moris ◽  
Helen Sarlanis ◽  
Marina Tsoli ◽  
...  

2009 ◽  
Vol 9 (4) ◽  
pp. E4-E7 ◽  
Author(s):  
Melpomeni Peppa ◽  
Georgios Papaxoinis ◽  
Nikolaos Xiros ◽  
Dimitrios Hadjidakis ◽  
Sotirios A. Raptis ◽  
...  

2020 ◽  
Vol 8 (23) ◽  
pp. 6182-6188
Author(s):  
Xing-Miao Wang ◽  
Yi-Zi Cong ◽  
Guang-Dong Qiao ◽  
Song Zhang ◽  
Li-Juan Wang

2017 ◽  
Author(s):  
Anne Kuritzky ◽  
Laila Khazai ◽  
Roberto Diaz ◽  
Christine Laronga

The identification of an axillary metastasis in the absence of a primary breast cancer can pose a diagnostic and therapeutic dilemma. The clinician should first use more sensitive imaging modalities, such as breast magnetic resonance imaging, to attempt to find the primary index lesion. If the primary cancer remains occult and the molecular markers are consistent with a breast origin, then the recommended treatment includes multimodality therapy including surgery, chemotherapy/endocrine treatment, and radiation. Historically, the modified radical mastectomy was the standard of practice. Recently, in the era of improved adjuvant therapies, breast-conserving surgery with irradiation is also being considered. Multiple retrospective reviews have shown no difference in survival or recurrence with these two surgical pathways. However, due to the rare nature of this clinical presentation, no multiinstitutional or prospective clinical trial data are available.  Key words: axillary lymph node dissection, axillary metastasis, breast cancer, breast conservation, local recurrence, occult primary tumor, radiotherapy 


Sign in / Sign up

Export Citation Format

Share Document